Clinical Laboratory Technology (China) common mistakes
Clinical Laboratory Technology (China) · Understand the traps and how to avoid them.
Treating a biomarker as a diagnosis without the complete evidence.
The same marker change can occur in different biological and analytical contexts.
What to do instead
Integrate specimen quality, method, timing and qualified clinical interpretation.
Treating adjusted total calcium as measured ionized calcium.
The formula does not directly establish the active calcium fraction in every patient.
What to do instead
Use an appropriate direct ionized measurement when clinically required.
Ignoring a citrate collection-ratio problem.
Collection errors can distort clotting assays before biological interpretation begins.
What to do instead
Follow the validated specimen acceptance and recollection process.
Reporting species identity from one typical biochemical reaction.
Exceptions and related organisms can share the same feature.
What to do instead
Use the complete validated identification pathway and report only justified certainty.
Assuming one concentration method detects every parasite.
Recovery varies by organism, stage and preparation method.
What to do instead
Select complementary methods appropriate to the diagnostic question.
Calling a reactive infection screen definitive.
Window periods, false results and algorithm requirements affect interpretation.
What to do instead
Follow the actual current national diagnostic pathway and qualified reporting process.
Rerunning controls repeatedly until one passes.
This can hide an unresolved process failure and expose patients to invalid results.
What to do instead
Investigate, document and resolve the cause under the actual quality plan.
Using a biosafety cabinet as a universal chemical hood.
Cabinet designs do not provide identical volatile-chemical containment.
What to do instead
Use a procedure-specific risk assessment and suitable engineering controls.